ViriiSoma Pharmaceuticals

ViriiSoma Pharmaceuticals is a leading biotechnology and genetic engineering corporation headquartered in Withmore City. Its glass tower stands on Soma Street at Cobblestone Plaza in Gold Sector, housing corporate administration and Western Hemisphere research and development facilities.

VS specializes in changing the human body through pharmaceuticals, nanogenic treatments and genetic manipulation. Its businesses span physical and cognitive enhancement, disease management, cosmetic biomodification, and post-cloning treatments for Degenerative Clone Disorder.

Products and Technology

VS's injectable products are supplied in glass cartridges supported by aluminum frames bearing the ViriiSoma Pharmaceuticals name. Their contents carry warnings identifying them as live nanogenic cultures.

The company's enhancement range includes:

• Muscle Graft: Increased muscle mass.
• Synaptic Stimulus: Faster neural signaling and improved quickness.
• Cerebral Enhancement: Increased connections between brain neurons.
• Hemoglobin Replacement: Improved oxygen uptake and stamina.
• Enhanced Antibodies: Enhanced healing and immune response.
• Nanosurgeons: Bloodborne nanomachines designed to control bleeding.
• Toxin Binders: Improved processing and elimination of toxic chemicals.
• Artificial Gills: Underwater respiration.
• Pheromone Enhancer: Modification of chemical signals associated with social attraction and confidence.
• Metachrosis Skin: Adaptive pigmentation that aids concealment.
• Dermalweave: Thickened, hardened skin that provides bodily protection.
• Limbic Stimulator: Enhancement of confidence and well-being.
• X-Change: Modification of primary and secondary sexual characteristics.

VS also produces antigenic injections intended to reverse specific nanogenic modifications. Named treatments cover muscle, synaptic, cerebral, hemoglobin, pheromone, gill and limbic enhancements.

The corporation's cosmetic biotechnology includes body modification culture modules used to develop customized body sculptures. Its products place personal appearance alongside physical performance and health as aspects of the body that can be deliberately altered.

Corporate Holdings

Ambrosia Pharmaceuticals is a VS subsidiary specializing in designer chemicals and nanotechnology. It operates from a separate facility in northwestern Gold Sector near the Soma Street Mag-Lev station.

VS also acquired the cloned-pet company RePet following the 2106 Ferimid-Messisium Type K9 outbreak. Prices rose after the acquisition.

History

In 2072, ViriiSoma released a treatment and cure for Ebola-MX and agreed to supply it to the United Nations at cost.

In 2082, advances in genetic research enabled VS to offer human modifications incorporating non-human traits, helping establish animal-inspired cosmetic modification as an international fashion.